CLINICAL STUDY FOR DIAGNOSIS AND TREATMENT OF CANINE MAMMARY NEOPLASMS (CMNs) USING DIFFERENT MODALITIES

被引:5
作者
Gupta, Pankaj [1 ]
Raghunath, M. [1 ]
Gupta, A. K. [1 ]
Sharma, Ankur [1 ]
Kour, Kawardeep [1 ]
机构
[1] Guru Angad Dev Vet & Anim Sci Univ, Dept Vet Surg & Radiol, Ludhiana 141004, Punjab, India
关键词
Canines; Chemotherapy; CMNs; Tumors; CHEMOTHERAPY; CARCINOMA;
D O I
10.5958/j.0976-0555.48.1.009
中图分类号
S8 [畜牧、 动物医学、狩猎、蚕、蜂];
学科分类号
0905 ;
摘要
The study was performed on 40 canines presented with the history of any swelling or growth in one or all of the mammary glands. Signalment and history was recorded properly and then the animals were subjected to detailed physical examination. Fine needle aspiration biopsy (FNAB) of the tumorous mass was taken to give preliminary diagnosis. The distant metastasis was confirmed via lymph node palpation, chest radiography and ultrasonography. Based on treatment regimen followed the animals were divided into two groups: group I (n=29) in which only surgery was performed and group II (n=6) in which surgery as well as chemotherapy was performed while remaining 5 animals were not given any treatment. Different haematological (Hb, TLC, DLC and PCV) and biochemical (BUN, CRTN, ALT, AST, ALKP and TP) were recorded preoperatively, postoperatively and after chemotherapy at required intervals. In group II animals chemotherapy was started 15 days after surgery and the regimen followed was inj. Vincristine @ 0.5mg/m(2)BSA and inj. Methotrexate @ 9-15mg/m(2)BSA, i.v. on day 1 followed by tab. Cyclophosphamide @ 50mg/m(2) po from 2nd to 5th day. Maximum (57.5%) no. of cases were recorded in Samoyed breed and the median age of affected animals was 10.8 years (2-15). Diagnostic accuracy, sensitivity and specificity of FNAB were 77.14%, 78.78% and 100% respectively. 74.28% of cases showed pulmonary metastasis in lung radiography. All haematological and biochemical parameters remained within normal range during the course of therapy except significant decrease in ALKP values after surgery in both groups. Majority (96.96%) of the neoplasms were malignant and there was no significant difference in the mean survival time and survival rate after surgery in both groups and among different surgical technique. The most significant finding was that all the live animals in group II were less than 8 years of age suggesting that the combination used in the present study was safe and effective in comparatively young animals.
引用
收藏
页码:45 / 49
页数:5
相关论文
共 44 条
  • [41] Clinical outcomes of cetuximab-based treatment for distant metastatic head and neck squamous cell carcinoma: A real-world study using Taiwan Head Neck Society registry database
    Lu, Hsueh-Ju
    Hsieh, Meng-Che
    Wang, Hung-Ming
    Hsieh, Jason Chia-Hsun
    Yen, Chia-Jui
    Wu, Shang-Yin
    Huang, Huai-Cheng
    Wang, Hui-Ching
    Chu, Pen-Yuan
    Chen, Tien-Hua
    Chien, Chih-Yen
    Huang, Tai-Lin
    Chang, Yi-Fang
    Hua, Chun-Hung
    Lien, Ming-Yu
    Chen, Jo-Pai
    Lu, Wei-Chen
    Lin, Jin-Ching
    Wang, Chen-Chi
    Liu, Yi-Chun
    Yang, Muh-Hwa
    Lou, Pei-Jen
    [J]. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2024, 46 (05): : 1063 - 1073
  • [42] Clinical Study on Using 125I Seeds Articles Combined with Biliary Stent Implantation in the Treatment of Malignant Obstructive Jaundice
    Wang, Tao
    Liu, Sheng
    Zheng, Yan-Bo
    Song, Xue-Peng
    Sun, Bo-Lin
    Jiang, Wen-Jin
    Wang, Li-Gang
    [J]. ANTICANCER RESEARCH, 2017, 37 (08) : 4649 - 4653
  • [43] Assessing the effectiveness and safety of surufatinib versus everolimus or sunitinib in advanced neuroendocrine neoplasms: insights from a real-world, retrospective cohort study using propensity score and inverse probability treatment weighting analysis
    Zhu, Linhui
    Ye, Xuan
    She, Youjun
    Liu, Wensheng
    Hasegawa, Kiyoshi
    Rossi, Roberta Elisa
    Du, Qiong
    Zhai, Qing
    [J]. JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2024, 15 (02) : 689 - 709
  • [44] The WIRE study a phase II, multi-arm, multi-centre, non-randomised window-of-opportunity clinical trial platform using a Bayesian adaptive design for proof-of-mechanism of novel treatment strategies in operable renal cell cancer - a study protocol
    Ursprung, Stephan
    Mossop, Helen
    Gallagher, Ferdia A.
    Sala, Evis
    Skells, Richard
    Sipple, Jamal A. N.
    Mitchell, Thomas J.
    Chhabra, Anita
    Fife, Kate
    Matakidou, Athena
    Young, Gemma
    Walker, Amanda
    Thomas, Martin G.
    Ortuzar, Mireia Crispin
    Sullivan, Mark
    Protheroe, Andrew
    Oades, Grenville
    Venugopal, Balaji
    Warren, Anne Y.
    Stone, John
    Eisen, Tim
    Wason, James
    Welsh, Sarah J.
    Stewart, Grant D.
    [J]. BMC CANCER, 2021, 21 (01)